血塞通滴丸联合富马酸比索洛尔治疗慢性心力衰竭的效果

Objective To explore the efficacy and safety of Xuesaitong Dropping Pills combined with bisoprolol fumarate tablets for the treatment of chronic heart failure (CHF). Methods 112 CHF patients admitted to Fuyuan Community Health Service Center in Suining City from July 2023 to July 2024 were randomly divided into a control group (56 cases, treated with bisoprolol fumarate tablets) and a treatment group (56 cases, treated with Xuesaitong Dropping Pills combined with bisoprolol fumarate tablets), both groups were treated for one month. The clinical efficacy, cardiac function indicators, and incidence of adverse reactions were compared between the two groups. Results After one month of treatment, the total effective rate of the treatment group was higher than that of the control group (P＜0.05). The left ventricular ejection fraction (LVEF) increased in both groups, while the left ventricular end-diastolic diameter (LVEDD) and left ventricular end-systolic diameter (LVESD) decreased. The LVEF in the treatment group was higher than that in the control group, while LVEDD and LVESD were lower than those in the control group (P＜0.05). The incidence of adverse reactions in the treatment group was lower than that in the control group (P＜0.05). Conclusion The combination of Xuesaitong Dropping Pills and bisoprolol fumarate tablets exhibits good efficacy in the treatment of CHF.